Involvement of the Catecholamine Pathway in Glioblastoma Development

Glioblastoma (GBM) is the most aggressive tumor of the central nervous system (CNS). The standard of care improves the overall survival of patients only by a few months. Explorations of new therapeutic targets related to molecular properties of the tumor are under way. Even though neurotransmitters...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraboth, Zoltán, Kajtár, Bela, Gálik, Bence, Gyenesei, Attila, Miseta, Attila, Kalman, Bernadette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998903/
https://www.ncbi.nlm.nih.gov/pubmed/33806345
http://dx.doi.org/10.3390/cells10030549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998903/
https://www.ncbi.nlm.nih.gov/pubmed/33806345
http://dx.doi.org/10.3390/cells10030549

Ejemplares similares